Annual Meeting

Garcia uses mass spectrometry
to unravel the human epigenome

He will present his work at the 2020 ASBMB annual meeting Molecular & Cellular Proteomics session
Nivedita Uday Hegdekar
March 5, 2020

When Benjamin Garcia was introduced to mass spectrometry as an undergraduate researcher in Carlito Lebrilla’s lab at the University of California, Davis, he thought it was an “interesting and useful analytical technique,” he said. Little did he guess the central role it would play throughout his research career.

The ASBMB annual meeting at EB has been canceled. This decision comes as COVID-19 spreads, institutions restrict travel and jurisdictions declare states of emergency. Read the letter sent to attendees.
Garcia-Benjamin-300x300.jpg
Benjamin Garcia

“Lebrilla was an amazing mentor,” Garcia said. “Despite my limited knowledge in analytical chemistry, he treated me like a regular member of the group. I had the opportunity to collaborate with different researchers and meet future mentors. I enjoyed the scientific discovery process and decided to apply to graduate school.”

His timing could not have been better. In the early 2000s, the human genome just had been sequenced, and Garcia became interested in investigating the various proteins encoded by genes.

“Proteomics research was in its infancy, and MS opened up a lot of opportunities to explore the area,” he said. His interest in the subject led him to pursue doctoral research with Don Hunt at the University of Virginia.

Under the guidance of Hunt, whom he described as “brilliant and visionary,” Garcia studied tandem mass spectrometry of complex biological mixtures. By the time he earned his Ph.D. in chemistry in 2005, he was fully immersed in the field of proteomics.

“And after that, there was no looking back,” he said with a laugh.

Over the years, Garcia has established himself as a leader in mass spectrometry and proteomics. He serves on the editorial boards of several scientific journals, including Molecular & Cellular Proteomics, and has received numerous awards, including the Presidential Early Career Award for Scientists and Engineers.

Excited by the progress being made in large-scale omics, Garcia said he hopes scientists can apply their knowledge to eventually “reprogram a diseased epigenome” in various diseases.

Besides his regular responsibilities as a professor at the University of Pennsylvania, Garcia develops programs that support diversity and underrepresented minority scientists at the university. As the leader of a large and productive research group, he believes mentorship is a key aspect of scientific discovery.

“As a PI, the most enriching experience has been training and mentoring researchers from different walks of life,” he said.

Advanced MS approaches to elucidate the “diseased” epigenome

Benjamin Garcia’s research group has developed novel methodologies for MS analysis of histones for application in post-translational modifications and systems epigenetics. Their most recent approach shows promise in the analysis of isolated histones from human clinical samples. Advantages over standard proteomics experiments include its quicker sample run time and improved quantification.

The group has used MS for high-throughput global profiling of histone post-translational modifications to better understand several cellular mechanisms and diseases. For example, they recently unraveled how recurrent loss-of-function alterations in polycomb-repressive complex 2, a histone-modifying complex, drive the formation of cancer cells in malignant peripheral nerve sheath tumors, an aggressive sarcoma.

The group’s findings will help identify several epigenetic targets. The long-term goal is to treat diseases with histone-modifying enzymes or targeted small-molecule inhibitors.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Nivedita Uday Hegdekar

Nivedita Uday Hegdekar is a recent Ph.D. graduate in biochemistry and molecular biology from the University of Maryland, Baltimore.

Related articles

Adults grow new brain cells
Aswathy Ammothumkandy, Charles Liu & Michael A. Bonaguidi
Upcoming opportunities
ASBMB Today Staff
From the journals: JBC
Emily Ulrich

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

How military forensic scientists use DNA to solve mysteries
Jobs

How military forensic scientists use DNA to solve mysteries

Jan. 10, 2025

Learn how two analysts at the Armed Forces DNA Identification Laboratory use molecular biology and genetics to identify the remains of fallen troops.

A decade of teaching the Art of Science Communication
Feature

A decade of teaching the Art of Science Communication

Jan. 7, 2025

Why now, more than ever, scientists must be able to explain what they do to non-scientists.

Of genes, chromosomes and oratorios
Profile

Of genes, chromosomes and oratorios

Jan. 1, 2025

Jenny Graves has spent her life mapping genes and comparing genomes. Now she’s created a musical opus about evolution of life on this planet — bringing the same drive and experimentalism she brought to the study of marsupial chromosomes.

In memoriam: Margaret Fonda
In Memoriam

In memoriam: Margaret Fonda

Dec. 30, 2024

She taught biochemistry in a male-dominated department at a medical school and was an ASBMB member for more than 50 years.

Sung honored for research; Sliger, Young named astronaut scholars
Member News

Sung honored for research; Sliger, Young named astronaut scholars

Dec. 23, 2024

Patrick Sung receives the 2024 Basser Global Prize from the Basser Center for BRCA at Penn Medicine. A foundation created by Mercury 7 astronauts awards scholarships to Shelby Sliger and Tara Young.

‘Our work is about science transforming people’s lives’
Interview

‘Our work is about science transforming people’s lives’

Dec. 17, 2024

Ann West, chair of the ASBMB Public Affairs Advisory Committee, sits down Monica Bertagnolli, director of the National Institutes of Health.